SOMCL-863 is an orally active and selective c-Met tyrosine kinase inhibitor. It demonstrates potent antitumor efficacy in cellular assays and animal models, supporting its use in oncology research targeting c-Met-driven cancers.
Molecular Weight:
475.46
CAS Number:
[1452310-87-0]
Formula:
C23H24F3N5O3
Target:
Others,c-Met/HGFR
* VAT and and shipping costs not included. Errors and price changes excepted
